Brooks Laboratories: expansion at Baddi Unit completed

“Certain regulatory approvals are still awaited at its Vadodara (Gujarat) Unit and it is expected that commercial production will commence within next six months,” said the company in a BSE filing.

Mar 31, 2016 04:03 IST India Infoline News Service

News Newspaper Text
Brooks Laboratories has announced that expansion at its Baddi unit in Himachal Pradesh is completed.“Certain regulatory approvals are still awaited at its Vadodara (Gujarat) Unit and it is expected that commercial production will commence within next six months,” said the company in a BSE filing.

Brooks Laboratories Ltd ended at Rs. 84.2, down by Rs. 1.35 or 1.58% from its previous closing of Rs. 85.55 on the BSE.

The scrip opened at Rs. 91 and touched a high and low of Rs. 93 and Rs. 84.2 respectively. A total of 68318(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 138.51 crore.

The BSE group 'B' stock of face value Rs. 10 touched a 52 week high of Rs. 124.15 on 12-Jan-2016 and a 52 week low of Rs. 38.1 on 31-Mar-2015. Last one week high and low of the scrip stood at Rs. 92.6 and Rs. 79.5 respectively.

The promoters holding in the company stood at 60.62 % while Institutions and Non-Institutions held 0.01 % and 39.37 % respectively.

The stock traded below its 100 DMA. 

Related Story